Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors

NCT05194735 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Funding

Conditions

Gynecologic Cancer
Colorectal Cancer
Pancreatic Cancer
Non-small Cell Lung Cancer
Cholangiocarcinoma
Ovarian Cancer
Endometrial Cancer
Ovarian Carcinoma
Ovary Neoplasm
Squamous Cell Lung Cancer
Adenocarcinoma of Lung
Adenosquamous Cell Lung Cancer

Interventions

BIOLOGICAL: Neoantigen specific TCR-T cell drug product
BIOLOGICAL: Aldesleukin (IL-2)

Sponsor

Alaunos Therapeutics